Clinical Trials in Dallas

Showing 9541-9560 of 17,468 trials

A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)

NCT03350542

EVOLVE 48 is a prospective, open label, single arm, multi-center trial. The purpose of this study is to assess the FDA requirement for safety and effectiveness of the SYNERGY 48 mm Coronary Stent System for the treatment of subjects with atherosclerotic lesion(s) \> 34 mm and ≤ 44 mm in length (by visual estimate) in native coronary arteries ≥2.5 mm to ≤4.0 mm in diameter (by visual estimate).

Coronary Artery Disease

Boston Scientific Corporation100 participantsStarted Apr 2018

Birmingham, Alabama, United States • Saint Paul, Minnesota, United States • New York, New York, United States +12 more locations

COMPLETEDPhase 1< 1 mile

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

NCT03291288

This study has two parts. Part 1 will evaluate how pexidartinib affects the way the body processes CYP3A4 and CYP2C9 substrates using midazolam and tolbutamide, respectively, as probe agents. Part 2 will test the efficacy and safety of pexidartinib treatment in various tumor types. In Part 2, the same participants will continue to receive pexidartinib twice daily. Participants will be allowed to continue using pexidartinib as long as the participant derives benefit.

Drug Interaction Potential

Daiichi Sankyo32 participantsStarted Feb 2018

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Palo Alto, California, United States +8 more locations

A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Find Trials by Condition in Dallas

TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis

Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema

A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections

Maribavir for Prevention of CMV After Stem Cell Transplants

Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin

Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy

Lead Registry for Optim Leads

St. Jude Medical Product Longevity and Performance (SCORE) Registry

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

Tanezumab In Osteoarthritis Of The Hip Or Knee

Infant Formula and Toddler Drink Feeding Intervention

Application of Targeted Reinnervation for People With Transradial Amputation

PK and Safety of Midostaurin in Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial

Safety, Pharmacokinetics and Pharmacodynamics of BPS804 in Osteogenesis Imperfecta

Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis

A Study of CK-1827452 Infusion in Stable Heart Failure

Weight Patterns in the Month After Birth